Sort
50,496 grants matching “lung cancer”
Anti-inflammatory effects of Pioglitazone & Metformin for Lung Cancer Prevention
$547,860Research Inst Of Fox Chase Can Ctr · N01 · FY2012 · CA
Regulation of Mucous Cell Metaplasia in Asthma
$547,858Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2015 · HL
Project 3: Long Non-Coding RNAs and Cancer
$547,839David L Spector · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
Okazaki fragment maturation: mutagenesis and cell survival
$547,800Binghui Shen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Okazaki fragment maturation: mutagenesis and cell survival
$547,800Binghui Shen · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Meharry EXPORT Center for Health Disparities
$547,786Valerie C. Montgomery-Rice · Meharry Medical College · P20 · FY2007 · MD
KREBS CYCLE SIGNALING FOR THERAPY OF METASTATIC LUNG CANCER
$547,750Emory University · · FY2021 · Defense Health Agency
Targeting Tumors with NF1 Loss
$547,736Yolanda Sanchez · Dartmouth College · R01 · FY2016 · NS
Molecular screening: MALDI-TOF scanning of peptides (RMI)
$547,706Stephen J. Kron · University Of Chicago · R01 · FY2008 · HG
Preclinical Evaluation of Medications to Treat Polydrug Addiction
$547,592Nancy K. Mello · Mclean Hospital · R01 · FY2012 · DA
Molecular Immunology Core
$547,585Leslie S Kean · Massachusetts General Hospital · U19 · FY2023 · AI
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$547,579Elaine R Mardis · Washington University · U01 · FY2013 · GM
Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment
$547,576Laurie McLouth · University Of Kentucky · R01 · FY2023 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$547,494John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Strategies to predict and overcome resistance to cancer immunotherapy
$547,492Steven L Reiner · Columbia University Health Sciences · R01 · FY2025 · CA
Strategies to predict and overcome resistance to cancer immunotherapy
$547,492Steven L Reiner · Columbia University Health Sciences · R01 · FY2023 · CA
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial
$547,430Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Systemic RNA Delivery to Tumors
$547,422Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2017 · CA
Rapid and affordable magneto-nanosensors for ctDNA-guided lung cancer management
$547,412Shan X. Wang · Stanford University · R01 · FY2022 · CA
Stanford University NCTN- Network Lead Academic Site
$547,394Heather Ann Wakelee · Stanford University · U10 · FY2017 · CA
Deciphering the molecular control of intratumoral dendritic cells
$547,265Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
lncRNA regulation of glioblastoma progression and therapeutic resistance
$547,221Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
lncRNA regulation of glioblastoma progression and therapeutic resistance
$547,221Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Taxi STEP (Social networks, Technology, and Exercise through Pedometers)
$547,213Francesca M Gany · Sloan-Kettering Inst Can Research · U01 · FY2019 · MD
Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system
$547,183Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2025 · CA